Entrepreneur series: American-born Carla Meledandri is involved in her first startup commercialising her award-winning nanoparticle science.
Fiona Rotherham Tue, 27 Feb 2018
It has been a long process, says Carla Meledandri, from the first inkling her research could lead to potential commercial applications to co-founding a company selling to the world.
The spin-out company Silventum was set up in September last year to commercialise her novel nanochemistry
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).